Exchange: NASDAQ·Updated 11:36 AM EDT
GRI logo

GRI GRI Bio Inc

$1.93
$0.015
(0.79%)
Today
Mkt Cap$4.18M
Vol25,426.00

About GRI

GRI Bio, Inc. engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on its lead program, GRI-0621, an inhibitor of type 1 invariant Natural Killer T (iNKT) cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis. The company was founded in May 2009 and is headquartered in La Jolla, CA.
46

Neutral Sentiment

How do you feel about GRI?

Advertisement|Remove ads.